Related references
Note: Only part of the references are listed.Structural basis of influenza virus neutralization
Thomas Han et al.
YEAR IN IMMUNOLOGY (2011)
Vaccine design of hemagglutinin glycoprotein against influenza
Juine-Ruey Chen et al.
TRENDS IN BIOTECHNOLOGY (2011)
Expanding the Concept of Chemically Programmable Antibodies to RNA Aptamers: Chemically Programmed Biotherapeutics
Ulrich Wuellner et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Laninamivir Prodrug CS-8958, a Long-Acting Neuraminidase Inhibitor, Shows Superior Anti-Influenza Virus Activity after a Single Administration
Shuku Kubo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Potent Inhibition of HIV-1 Entry with a Chemically Programmed Antibody Aided by an Efficient Organocatalytic Synthesis
Julia Gavrilyuk et al.
CHEMBIOCHEM (2010)
Influenza Hemagglutinin and Neuraminidase Membrane Glycoproteins
Steven J. Gamblin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Efficacy of the New Neuraminidase Inhibitor CS-8958 against H5N1 Influenza Viruses
Maki Kiso et al.
PLOS PATHOGENS (2010)
Analysis and Optimization of Copper-Catalyzed Azide-Alkyne Cycloaddition for Bioconjugation
Vu Hong et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
An efficient chemical approach to bispecific antibodies and antibodies of high valency
Julia I. Gavrilyuk et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
β-Lactam-based approach for the chemical programming of aldolase antibody 38C2
Julia I. Gavrilyuk et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Synthesis and in vivo influenza virus-inhibitory effect of ester prodrug of 4-guanidino-7-O-methyl-Neu5Ac2en
Takeshi Honda et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Direct Observation of an Enamine Intermediate in Amine Catalysis
Xueyong Zhu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
An Antibody-Recruiting Small Molecule That Targets HIV gp120
Christopher G. Parker et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Chemical Control over Immune Recognition: A Class of Antibody-Recruiting Small Molecules That Target Prostate Cancer
Ryan P. Murelli et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic
Gavin J. D. Smith et al.
NATURE (2009)
Emergence and pandemic potential of swine-origin H1N1 influenza virus
Gabriele Neumann et al.
NATURE (2009)
Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team
Fatimah S. Dawood et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Instant immunity through chemically programmable vaccination and covalent self-assembly
Mikhail Popkov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans
Rebecca J. Garten et al.
SCIENCE (2009)
Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants
Patrick J. Collins et al.
NATURE (2008)
The war against influenza: discovery and development of sialidase inhibitors
Mark von Itzstein
NATURE REVIEWS DRUG DISCOVERY (2007)
Benzimidazole and related Ligands for Cu-catalyzed azide-alkyne cycloaddition
Valentin O. Rodionov et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Synthesis of C-4 and C-7 triazole analogs of zanamivir as multivalent sialic acid containing scaffolds
Yan Lu et al.
CARBOHYDRATE RESEARCH (2007)
Chemically programmed antibodies:: Endothelin receptor targeting CovX-Bodies™
Venkata R. Doppalapudi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Preparation of integrin alpha(v) beta(3)-targeting Ab 38C2 constructs
Subhash C. Sinha et al.
NATURE PROTOCOLS (2007)
Small molecule drug activity in melanoma models may be dramatically enhanced with an antibody effector
Mikhail Popkov et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Drug therapy - Neuraminidase inhibitors for influenza
A Moscona
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenza
SJF Macdonald et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase
KG Watson et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Polytriazoles as copper(I)-stabilizing ligands in catalysis
TR Chan et al.
ORGANIC LETTERS (2004)
Potent and long-acting dimeric inhibitors of influenza virus neuraminidase are effective at a once-weekly dosing regimen
SJ Macdonald et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Are we ready for pandemic influenza?
RJ Webby et al.
SCIENCE (2003)
A humanized aldolase antibody for selective chemotherapy and adaptor immunotherapy
C Rader et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Chemically programmed monoclonal antibodies for cancer therapy: Adaptor immunotherapy based on a covalent antibody catalyst
C Rader et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Synthesis and anti-influenza evaluation of polyvalent sialidase inhibitors bearing 4-guanidino-Neu5Ac2en derivatives
T Masuda et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2003)
Synthesis and anti-influenza virus activity of 4-guanidino-7-substituted Neu5Ac2en derivatives
T Honda et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2002)
Synthesis and anti-influenza virus activity of 7-O-alkylated derivatives related to zanamivir
T Honda et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2002)
Synthesis and anti-influenza evaluation of polyvalent sialidase inhibitors bearing 4-guanidino-Neu5Ac2en derivatives
T Honda et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2002)
Share Paper
